Please login to the form below

Not currently logged in
Email:
Password:

NICE appoints Andy McKeon to Board

The National Institute for Health and Clinical Excellence has appointed Andy McKeon as a non-executive member of its Board

The National Institute for Health and Clinical Excellence (NICE) has appointed Andy McKeon as a non-executive member of its Board.

McKeon, who is managing director of health at the Audit Commission, will replace Mark Taylor who stepped down in April to take up the role of chair at an NHS Mental Health Trust.

Before joining the Audit Commission, McKeon was director of policy and planning at the Department of Health (DH) with responsibility for setting targets for the reform and improvement of health and social care policy agenda. During his time in post he was responsible for all aspects of the clinical and cost effective use of medicines in the NHS.

Mercy Jeyasingham, MBE, has been reappointed to her non-executive role on NICE's board for a further two-year term. A former member of the Ministerial Advisory Board for the Medicines Control Agency, Mercy is a management consultant and trainer who has held significant senior roles in both the public and voluntary sectors.

The appointments were made by the independent organisation the Appointments Commission which is responsible for appointing chairs and non-executive directors to NHS organisations on behalf of the Secretary of State for Health.

 

25th June 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics